Sharps Technology Inc.
4.9600-0.19 (-3.69%)
Oct 29, 4:00:00 PM EDT · NasdaqCM · STSS · USD
Key Stats
Market Cap
140.00MP/E (TTM)
-Basic EPS (TTM)
-1196.84Dividend Yield
0%Recent Filings
8-K
Stockholders approve director, share issuances
Sharps Technology stockholders overwhelmingly elected Annemarie Tierney as a new director at the October 14, 2025 special meeting, with 17.8 million votes in favor amid zero opposition. They also greenlit issuing up to 56 million shares via cryptocurrency-linked warrants and 6.3 million via Sol Markets warrants, complying with Nasdaq rules to unlock potential capital inflows. Yet dilution looms large for existing holders.
8-K
Sharps settles suit, divests subsidiary
Sharps Technology settled ongoing litigation with Barry Berler and Plasto entities on October 6, 2025, dismissing all claims without admitting fault. The deal transfers patents, trademarks, certain assets, and full ownership of Hungarian subsidiary Safegard Medical Kft to Plasto Technology Group, while Sharps cancels specific Provensa marks and retains a 15% cut on future patent sales. Pro forma figures show reduced assets by $7.6 million and improved six-month net income to $7.1 million, shedding operational drag. Litigation ends cleanly.
8-K
Registration filing deadline extended
Sharps Technology secured a waiver from key security holders on September 26, 2025, extending the deadline to file its initial resale registration statement from September 29 to 60 days post-Closing Date under the August 25 Registration Rights Agreement. This adjustment, backed by holders of over 50% of registrable securities, eases immediate filing pressures while preserving other obligations. No financial impacts disclosed. Waiver limited to this extension.
8-K
Closes $411M Solana treasury raise
Sharps Technology closed a $410.88 million private placement on August 28, 2025, issuing common stock, pre-funded warrants, and stapled warrants exercisable at $9.75 for up to 63 million additional shares. Proceeds fund a Solana treasury strategy, acquiring over 2 million SOL via open-market buys, with a 20-year consulting deal for asset management and a 2-year strategic advisory pact granting 10% warrants. This pivot bolsters crypto exposure but ties up capital amid SOL volatility risks.
8-K
ATM equity sales agreement
Sharps Technology inked a sales agreement on September 2, 2025, with Cantor Fitzgerald and Aegis Capital to sell up to $236,605,575 in common stock via at-the-market offerings. Agents earn a 3.0% commission on gross proceeds, with sales at the company's discretion through normal trading channels. No obligation to sell exists. This setup bolsters funding flexibility amid market volatility.
IPO
Website
Employees
Sector
Industry
MHUA
Meihua International Medical Te
0.23-0.03
MLSS
Milestone Scientific, Inc.
0.43-0.03
RVP
Retractable Technologies, Inc.
0.90-0.01
SHTPY
-
7.65+0.00
STAA
STAAR Surgical Company
26.59-0.57
STE
STERIS plc (Ireland)
236.79-4.41
STVN
Stevanato Group S.p.A.
25.80+0.02
STXS
Stereotaxis, Inc.
2.92-0.05
SYK
Stryker Corporation
369.59-6.34
WST
West Pharmaceutical Services, I
284.86+1.37